# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-109383
Filing Date
2022-10-17
Accepted
2022-10-17 17:11:12
Documents
4
Period of Report
2022-11-16

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm2211316-1_def14a.htm | DEF 14A | 557868
2 | GRAPHIC | sg_juleshaimovitz-bw.jpg | GRAPHIC | 17764
3 | GRAPHIC | tm2211316d1-px_proxy14c.jpg | GRAPHIC | 860763
4 | GRAPHIC | tm2211316d1-px_proxy24c.jpg | GRAPHIC | 583698
| Complete submission text file | 0001104659-22-109383.txt |  | 2573151

Mailing Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292
Business Address 4503 GLENCOE AVENUE MARINA DEL REY CA 90292 310-665-2928
Armata Pharmaceuticals, Inc. (Filer) CIK: 0000921114 (see all company filings)

EIN.: 911549568 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37544 | Film No.: 221314275
SIC: 2836 Biological Products, (No Diagnostic Substances)